Published in Pediatr Blood Cancer on September 01, 2010
A Randomized Trial of LOVAZA in Pediatric Sickle Cell Disease (SCD) | NCT01202812
Gaming Technology to Engage Adolescent Sickle Cell Patients in Pain Management | NCT03291613
Beyond the definitions of the phenotypic complications of sickle cell disease: an update on management. ScientificWorldJournal (2012) 1.40
Health related quality of life among adolescents with sickle cell disease in Saudi Arabia. Pan Afr Med J (2011) 1.04
Emerging science of hydroxyurea therapy for pediatric sickle cell disease. Pediatr Res (2013) 1.03
PedsQL™ sickle cell disease module: feasibility, reliability, and validity. Pediatr Blood Cancer (2013) 1.00
Differences in health-related quality of life in children with sickle cell disease receiving hydroxyurea. J Pediatr Hematol Oncol (2011) 0.97
Patterns of opioid use in sickle cell disease. Am J Hematol (2016) 0.95
High dose vitamin D therapy for chronic pain in children and adolescents with sickle cell disease: results of a randomized double blind pilot study. Br J Haematol (2012) 0.94
Sleep disturbance, depression and pain in adults with sickle cell disease. BMC Psychiatry (2014) 0.94
Development of the PedsQL™ Sickle Cell Disease Module items: qualitative methods. Qual Life Res (2011) 0.93
PedsQL™ Multidimensional Fatigue Scale in sickle cell disease: feasibility, reliability, and validity. Pediatr Blood Cancer (2013) 0.88
Fatigue in adolescents and young adults with sickle cell disease: biological and behavioral correlates and health-related quality of life. J Pediatr Oncol Nurs (2013) 0.87
PROMIS(®) pediatric self-report scales distinguish subgroups of children within and across six common pediatric chronic health conditions. Qual Life Res (2015) 0.87
Predictors of Academic Achievement for School Age Children with Sickle Cell Disease. Adv Sch Ment Health Promot (2013) 0.86
PedsQL™ Cognitive Functioning Scale in pediatric liver transplant recipients: feasibility, reliability, and validity. Qual Life Res (2010) 0.85
Health-related quality of life in patients with sickle cell disease in Saudi Arabia. Health Qual Life Outcomes (2015) 0.81
Health-related quality of life (HRQL) in children with sickle cell disease and thalassemia following hematopoietic stem cell transplant (HSCT). Pediatr Blood Cancer (2011) 0.80
Responsiveness of the PedsQL to pain-related changes in health-related quality of life in pediatric sickle cell disease. J Pediatr Psychol (2012) 0.79
Health-related quality of life in children with sickle cell disease using the child health questionnaire. J Pediatr Health Care (2012) 0.79
Insurance status as a sociodemographic risk factor for functional outcomes and health-related quality of life among youth with sickle cell disease. J Pediatr Hematol Oncol (2014) 0.79
Pain characteristics and age-related pain trajectories in infants and young children with sickle cell disease. Pediatr Blood Cancer (2013) 0.78
Parental problem-solving abilities and the association of sickle cell disease complications with health-related quality of life for school-age children. J Clin Psychol Med Settings (2014) 0.77
Community Health Workers as Support for Sickle Cell Care. Am J Prev Med (2016) 0.76
Lessons Learned From a Randomized Controlled Trial of a Family-Based Intervention to Promote School Functioning for School-Age Children With Sickle Cell Disease. J Pediatr Psychol (2015) 0.76
Psychometric Evaluation of the Patient-Reported Outcomes Measurement Information System Fatigue-Short Form Across Diverse Populations. Nurs Res (2016) 0.75
Responsiveness of PROMIS(®) Pediatric Measures to Hospitalizations for Sickle Pain and Subsequent Recovery. Pediatr Blood Cancer (2016) 0.75
Comorbidity, Pain, Utilization, and Psychosocial Outcomes in Older versus Younger Sickle Cell Adults: The PiSCES Project. Biomed Res Int (2017) 0.75
Initial Evaluation of the Pediatric PROMIS® Health Domains in Children and Adolescents With Sickle Cell Disease. Pediatr Blood Cancer (2016) 0.75
Pain in sickle cell disease. Rates and risk factors. N Engl J Med (1991) 9.75
The PedsQL 4.0 as a pediatric population health measure: feasibility, reliability, and validity. Ambul Pediatr (2003) 8.61
The PedsQL in type 1 and type 2 diabetes: reliability and validity of the Pediatric Quality of Life Inventory Generic Core Scales and type 1 Diabetes Module. Diabetes Care (2003) 5.62
The PedsQL in pediatric cancer: reliability and validity of the Pediatric Quality of Life Inventory Generic Core Scales, Multidimensional Fatigue Scale, and Cancer Module. Cancer (2002) 5.30
Deconstructing sickle cell disease: reappraisal of the role of hemolysis in the development of clinical subphenotypes. Blood Rev (2006) 4.46
Clinical events in the first decade in a cohort of infants with sickle cell disease. Cooperative Study of Sickle Cell Disease. Blood (1995) 4.18
Impaired health-related quality of life in children and adolescents with chronic conditions: a comparative analysis of 10 disease clusters and 33 disease categories/severities utilizing the PedsQL 4.0 Generic Core Scales. Health Qual Life Outcomes (2007) 3.63
Parent proxy-report of their children's health-related quality of life: an analysis of 13,878 parents' reliability and validity across age subgroups using the PedsQL 4.0 Generic Core Scales. Health Qual Life Outcomes (2007) 3.43
The PedsQL in pediatric asthma: reliability and validity of the Pediatric Quality of Life Inventory generic core scales and asthma module. J Behav Med (2004) 2.85
Health-related quality of life in children with sickle cell disease: child and parent perception. Br J Haematol (2005) 2.16
The PedsQL in pediatric cerebral palsy: reliability, validity, and sensitivity of the Generic Core Scales and Cerebral Palsy Module. Dev Med Child Neurol (2006) 2.12
Home management of pain in sickle cell disease: a daily diary study in children and adolescents. J Pediatr Hematol Oncol (2002) 1.94
Parental report of health-related quality of life in children with sickle cell disease. J Behav Med (2002) 1.80
Validity of the child health questionnaire for use in children with sickle cell disease. J Pediatr Hematol Oncol (2004) 1.46
Home management of sickle cell-related pain in children and adolescents: natural history and impact on school attendance. Pain (1995) 1.44
The performance of the PedsQL generic core scales in children with sickle cell disease. J Pediatr Hematol Oncol (2008) 1.42
Variation in hospitalizations and hospital length of stay in children with vaso-occlusive crises in sickle cell disease. Pediatr Blood Cancer (2005) 1.35
Characteristics of pain managed at home in children and adolescents with sickle cell disease by using diary self-reports. J Pain (2002) 1.22
The PedsQL in pediatric cancer pain: a prospective longitudinal analysis of pain and emotional distress. J Dev Behav Pediatr (2004) 1.21
Sickle cell vaso-occlusion. Hematol Oncol Clin North Am (2005) 1.20
Brief report: Academic attainment in children with sickle cell disease. J Pediatr Psychol (2004) 1.20
Pulmonary hypertension in sickle cell disease: mechanisms, diagnosis, and management. Hematol Oncol Clin North Am (2005) 1.08
A multidisciplinary health care team's efforts to improve educational attainment in children with sickle-cell anemia and cerebral infarcts. J Sch Health (2006) 1.05
Postdischarge pain, functional limitations and impact on caregivers of children with sickle cell disease treated for painful events. Br J Haematol (2008) 1.04
Validity of the Pediatric Quality Of Life Inventory for youth with sickle cell disease. J Pediatr Psychol (2008) 1.02
Definitions of the phenotypic manifestations of sickle cell disease. Am J Hematol (2010) 2.55
High prevalence of red blood cell alloimmunization in sickle cell disease despite transfusion from Rh-matched minority donors. Blood (2013) 2.41
Progressive periodontal disease and risk of very preterm delivery. Obstet Gynecol (2006) 2.00
Serum ferritin level changes in children with sickle cell disease on chronic blood transfusion are nonlinear and are associated with iron load and liver injury. Blood (2009) 1.83
Pulmonary hypertension in sickle cell disease. Am J Med (2004) 1.76
Predictors of fetal hemoglobin response in children with sickle cell anemia receiving hydroxyurea therapy. Blood (2002) 1.52
Silent infarcts in young children with sickle cell disease. Br J Haematol (2009) 1.51
Risk of recurrent stroke in children with sickle cell disease receiving blood transfusion therapy for at least five years after initial stroke. J Pediatr (2002) 1.50
Morbidity and mortality in chronically transfused subjects with thalassemia and sickle cell disease: A report from the multi-center study of iron overload. Am J Hematol (2007) 1.39
Summary of symposium: the future of stem cell transplantation for sickle cell disease. J Pediatr Hematol Oncol (2002) 1.37
Extranodal Rosai-Dorfman disease in children. J Pediatr Hematol Oncol (2004) 1.23
Longitudinal changes in ferritin during chronic transfusion: a report from the Stroke Prevention Trial in Sickle Cell Anemia (STOP). J Pediatr Hematol Oncol (2002) 1.22
Sickle cell hepatopathy: clinical presentation, treatment, and outcome in pediatric and adult patients. Pediatr Blood Cancer (2005) 1.21
Transcranial Doppler ultrasonography and prophylactic transfusion program is effective in preventing overt stroke in children with sickle cell disease. J Pediatr (2010) 1.21
Parent factors and adolescent sickle cell disease: associations with patterns of health service use. J Pediatr Psychol (2002) 1.19
Cognitive impairment in children with hemoglobin SS sickle cell disease: relationship to MR imaging findings and hematocrit. AJNR Am J Neuroradiol (2003) 1.15
Health-related quality of life in adults with sickle cell disease (SCD): a report from the comprehensive sickle cell centers clinical trial consortium. Am J Hematol (2011) 1.15
Is treatment adherence associated with better quality of life in children with sickle cell disease? Qual Life Res (2005) 1.11
Effect of hydroxyurea on growth in children with sickle cell anemia: results of the HUG-KIDS Study. J Pediatr (2002) 1.07
Recruitment of infants with sickle cell anemia to a Phase III trial: data from the BABY HUG study. Contemp Clin Trials (2010) 1.07
Magnetic resonance angiography in children with sickle cell disease and abnormal transcranial Doppler ultrasonography findings enrolled in the STOP study. Blood (2003) 1.06
Alpha Thalassemia is associated with decreased risk of abnormal transcranial Doppler ultrasonography in children with sickle cell anemia. J Pediatr Hematol Oncol (2003) 1.05
Streptococcus pneumoniae sepsis and meningitis during the penicillin prophylaxis era in children with sickle cell disease. J Pediatr Hematol Oncol (2002) 1.04
Maternal serum C-reactive protein concentration early in pregnancy and subsequent pregnancy loss. Am J Perinatol (2005) 1.03
Evaluation of a comprehensive transcranial doppler screening program for children with sickle cell anemia. Pediatr Blood Cancer (2008) 1.03
Initial development of a questionnaire evaluating perceived benefits and barriers to pediatric clinical trials participation. Contemp Clin Trials (2012) 1.02
Therapy preference and decision-making among patients with severe sickle cell anemia and their families. Pediatr Blood Cancer (2007) 1.02
Genomic structure of the PIK3CG gene on chromosome band 7q22 and evaluation as a candidate myeloid tumor suppressor. Blood (2002) 1.00
Refining the value of secretory phospholipase A2 as a predictor of acute chest syndrome in sickle cell disease: results of a feasibility study (PROACTIVE). Br J Haematol (2012) 0.99
The effects of hydroxycarbamide and magnesium on haemoglobin SC disease: results of the multi-centre CHAMPS trial. Br J Haematol (2011) 0.98
IMPROVE trial: a randomized controlled trial of patient-controlled analgesia for sickle cell painful episodes: rationale, design challenges, initial experience, and recommendations for future studies. Clin Trials (2013) 0.96
Recommendations for staff education and training for older people with mental illness in long-term aged care. Int Psychogeriatr (2010) 0.94
Sickle cell disease summit: from clinical and research disparity to action. Am J Hematol (2009) 0.93
Tapered oral dexamethasone for the acute chest syndrome of sickle cell disease. Br J Haematol (2011) 0.92
Anxiety and depression in children and adolescents with sickle cell disease. Curr Psychiatry Rep (2007) 0.91
Positive blood cultures in sickle cell disease: time to positivity and clinical outcome. J Pediatr Hematol Oncol (2003) 0.90
Non-invasive measurements of carboxyhemoglobin and methemoglobin in children with sickle cell disease. Pediatr Pulmonol (2012) 0.89
Brain parenchymal damage after haematopoietic stem cell transplantation for severe sickle cell disease. Br J Haematol (2005) 0.88
Respiratory muscle force and lung volume changes in a population of children with sickle cell disease. Br J Haematol (2013) 0.88
Diagnosis and treatment of pediatric acquired aplastic anemia (AAA): an initial survey of the North American Pediatric Aplastic Anemia Consortium (NAPAAC). Pediatr Blood Cancer (2013) 0.88
Association of hospital and provider types on sickle cell disease outcomes. Pediatrics (2013) 0.86
Periodic limb movements and disrupted sleep in children with sickle cell disease. Sleep (2011) 0.86
Comparison of transcranial Doppler sonography with and without imaging in the evaluation of children with sickle cell anemia. AJR Am J Roentgenol (2004) 0.86
Upper airway lymphoid tissue size in children with sickle cell disease. Chest (2012) 0.85
Transcranial Doppler ultrasonography in siblings with sickle cell disease. Br J Haematol (2003) 0.85
Toward a common understanding: supporting and promoting education scholarship for medical school faculty. Med Educ (2014) 0.84
UGT1A1 promoter polymorphisms and the development of hyperbilirubinemia and gallbladder disease in children with sickle cell anemia. Am J Hematol (2008) 0.84
Local linear discriminant analysis (LLDA) for group and region of interest (ROI)-based fMRI analysis. Neuroimage (2007) 0.84
Validation of the sickle cell disease pain burden interview-youth. J Pain (2013) 0.82
Oral glutamine supplementation decreases resting energy expenditure in children and adolescents with sickle cell anemia. J Pediatr Hematol Oncol (2004) 0.82
Psychiatric diagnosis in adolescents with sickle cell disease: a preliminary report. Curr Psychiatry Rep (2011) 0.81
Chronic transfusion therapy for children with sickle cell disease and recurrent acute chest syndrome. J Pediatr Hematol Oncol (2005) 0.81
Upper airway genioglossal activity in children with sickle cell disease. Sleep (2011) 0.81
Headache in children with sickle cell disease: prevalence and associated factors. J Pediatr (2007) 0.81
The research innovation and scholarship in education program: an innovative way to nurture education. Acad Psychiatry (2009) 0.80
Treatment of children with Langerhans cell histiocytosis with 2-chlorodeoxyadenosine. Am J Hematol (2002) 0.80
Pneumococcal bacteremia in a vaccinated pediatric sickle cell disease population. Pediatr Infect Dis J (2012) 0.80
Canadian residents' perceived manager training needs. Med Teach (2010) 0.79
The painful face of poverty. Pediatr Blood Cancer (2009) 0.79
Transfusion and chelation practices in sickle cell disease: a regional perspective. Pediatr Hematol Oncol (2010) 0.79
Screening U.S. college athletes for their sickle cell disease carrier status. Am J Prev Med (2011) 0.79
Biloma and pneumobilia in sickle cell disease. Pediatr Blood Cancer (2008) 0.77
Safety and Efficacy of High-dose Daily Vitamin D3 Supplementation in Children and Young Adults With Sickle Cell Disease. J Pediatr Hematol Oncol (2015) 0.77
Knowledge of stroke risk, signs of stroke, and the need for stroke education among children with sickle cell disease and their caregivers. Ethn Health (2002) 0.77
Epidemiology of bloodstream infections in children with sickle cell disease. Pediatr Infect Dis J (2013) 0.76
Hemoglobin to Hematocrit Ratio: The Strongest Predictor of Femoral Head Osteonecrosis in Children With Sickle Cell Disease. J Pediatr Orthop (2016) 0.75
Magnetic resonance imaging in children with sickle cell disease--detecting alterations in the apparent diffusion coefficient in hips with avascular necrosis. Pediatr Radiol (2011) 0.75
False-positive pregnancy test after passive transfusion of beta-human chorionic gonadotropin from donor red blood cells during erythrocytapheresis. Transfusion (2007) 0.75
Asymptomatic factor VII deficiency in African Americans. Am J Clin Pathol (2006) 0.75
Comparison of energy prediction equations with measured resting energy expenditure in children with sickle cell anemia. J Am Diet Assoc (2002) 0.75
Thrombocytosis in an infant with high thrombopoietin concentrations. J Pediatr Hematol Oncol (2004) 0.75
Integrating Quality Improvement and Continuing Professional Development: A Model From the Mental Health Care System. Acad Med (2016) 0.75
Oral Glutamine Supplementation Decreases Resting Energy Expenditure in Children and Adolescents With Sickle Cell Anemia. J Pediatr Hematol Oncol (2004) 0.75
Attenuated Plantar Flexor Strength In Children With Type SS Sickle Cell Disease: 3667 Board #106 June 4, 8: 00 AM - 9: 30 AM. Med Sci Sports Exerc (2016) 0.75